Single versus multifraction radiotherapy for spinal cord compression: A systematic review and meta-analysis.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
05 2019
Historique:
received: 25 09 2018
revised: 14 01 2019
accepted: 15 01 2019
entrez: 22 4 2019
pubmed: 22 4 2019
medline: 28 3 2020
Statut: ppublish

Résumé

While multifraction radiotherapy (RT) regimens (MFRT) have been considered the standard of care in patients with metastatic epidural spinal cord compression (MESCC) with limited prognosis, recent randomized evidence has demonstrated that single fraction RT (SFRT) may be equivalent in terms of functional and overall outcomes. A systematic review and meta-analysis was conducted to determine the effects of SFRT compared to short course MFRT in patients with MESCC. A search of OVID, EMBASE, and the Cochrane Central Register of Controlled Trials from inception to February 2018 was conducted. Randomized and prospective non-randomized trials comparing SFRT and short course MFRT for MESCC were included. Data were analyzed using a random effects model, and relative risks (RR) or hazard ratios (HR) were reported with corresponding 95% confidence intervals (CI). Quality of evidence was assessed using the GRADE criteria. Overall 1717 articles were reviewed. Three randomized trials were eligible for inclusion (n = 712 patients). The pooled treatment effect for SFRT versus MFRT with respect to motor response was RR = 0.96 (95% CI = 0.86-1.07, I

Sections du résumé

BACKGROUND
While multifraction radiotherapy (RT) regimens (MFRT) have been considered the standard of care in patients with metastatic epidural spinal cord compression (MESCC) with limited prognosis, recent randomized evidence has demonstrated that single fraction RT (SFRT) may be equivalent in terms of functional and overall outcomes. A systematic review and meta-analysis was conducted to determine the effects of SFRT compared to short course MFRT in patients with MESCC.
METHODS
A search of OVID, EMBASE, and the Cochrane Central Register of Controlled Trials from inception to February 2018 was conducted. Randomized and prospective non-randomized trials comparing SFRT and short course MFRT for MESCC were included. Data were analyzed using a random effects model, and relative risks (RR) or hazard ratios (HR) were reported with corresponding 95% confidence intervals (CI). Quality of evidence was assessed using the GRADE criteria.
RESULTS
Overall 1717 articles were reviewed. Three randomized trials were eligible for inclusion (n = 712 patients). The pooled treatment effect for SFRT versus MFRT with respect to motor response was RR = 0.96 (95% CI = 0.86-1.07, I

Identifiants

pubmed: 31005225
pii: S0167-8140(19)30024-6
doi: 10.1016/j.radonc.2019.01.019
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

55-66

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Elysia K Donovan (EK)

Department of Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, Canada. Electronic address: donovane@hhsc.ca.

Julianna Sienna (J)

Department of Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, Canada.

Gunita Mitera (G)

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.

Nidhi Kumar-Tyagi (N)

Department of Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, Canada.

Sameer Parpia (S)

Department of Statistics and Epidemiology, Department of Oncology, McMaster University, Hamilton, Canada.

Anand Swaminath (A)

Department of Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH